CME GROUP INC. Quarterly Operating Income (Loss) in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Cme Group Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2010 to Q3 2024.
  • Cme Group Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was $1.02B, a 24.9% increase year-over-year.
  • Cme Group Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was $3.85B, a 18.7% increase year-over-year.
  • Cme Group Inc. annual Operating Income (Loss) for 2023 was $3.44B, a 13.9% increase from 2022.
  • Cme Group Inc. annual Operating Income (Loss) for 2022 was $3.02B, a 14% increase from 2021.
  • Cme Group Inc. annual Operating Income (Loss) for 2021 was $2.65B, a 0.3% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $3.85B $1.02B +$204M +24.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $3.64B $1B +$162M +19.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $3.48B $960M +$45.9M +5.02% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $3.44B $863M +$195M +29.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $3.24B $820M +$81.4M +11% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 $3.16B $839M +$88.9M +11.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 $3.07B $914M +$54.6M +6.36% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 $3.02B $668M +$36.6M +5.79% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $2.98B $739M +$125M +20.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $2.85B $750M +$75M +11.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $2.78B $859M +$134M +18.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $2.65B $632M +$117M +22.7% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $2.53B $614M +$88.7M +16.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $2.44B $675M +$37.2M +5.84% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $2.4B $725M -$235M -24.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $2.64B $515M -$58M -10.1% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-26
Q3 2020 $2.7B $525M -$160M -23.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $2.86B $638M -$61.1M -8.75% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $2.92B $960M +$329M +52.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $2.59B $573M -$76.9M -11.8% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-26
Q3 2019 $2.66B $685M +$135M +24.6% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-26
Q2 2019 $2.53B $699M +$31.7M +4.75% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-26
Q1 2019 $2.5B $631M -$110M -14.8% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-26
Q4 2018 $2.61B $650M +$113M +21% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-28
Q3 2018 $2.49B $550M -$17.7M -3.12% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-28
Q2 2018 $2.51B $667M +$61.7M +10.2% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-28
Q1 2018 $2.45B $741M +$140M +23.3% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-28
Q4 2017 $2.31B $537M -$3.3M -0.61% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-28
Q3 2017 $2.31B $568M +$42.3M +8.05% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-28
Q2 2017 $2.27B $605M +$41.9M +7.44% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-28
Q1 2017 $2.23B $601M +$27M +4.71% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-28
Q4 2016 $2.2B $540M +$70.3M +15% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-01
Q3 2016 $2.13B $525M +$8.9M +1.72% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-01
Q2 2016 $2.12B $563M +$68.2M +13.8% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-01
Q1 2016 $2.06B $574M +$66.6M +13.1% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-01
Q4 2015 $1.99B $470M -$1.6M -0.34% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-27
Q3 2015 $1.99B $516M +$86M +20% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-27
Q2 2015 $1.9B $495M +$83.1M +20.2% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-27
Q1 2015 $1.82B $507M +$52.8M +11.6% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-27
Q4 2014 $1.77B $472M +$148M +45.9% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-26
Q3 2014 $1.62B $430M +$29.9M +7.47% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-26
Q2 2014 $1.59B $412M -$95.8M -18.9% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-26
Q1 2014 $1.69B $455M +$49M +12.1% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-26
Q4 2013 $1.64B $323M -$52.4M -14% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-26
Q3 2013 $1.69B $401M +$4.5M +1.14% Jul 1, 2013 Sep 30, 2013 10-K 2015-02-26
Q2 2013 $1.68B $508M +$38.6M +8.23% Apr 1, 2013 Jun 30, 2013 10-K 2015-02-26
Q1 2013 $1.65B $406M -$45.7M -10.1% Jan 1, 2013 Mar 31, 2013 10-K 2015-02-26
Q4 2012 $1.69B $376M -$14.8M -3.79% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-03
Q3 2012 $1.71B $396M -$176M -30.8% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-03
Q2 2012 $1.88B $469M -$65.3M -12.2% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-03
Q1 2012 $1.95B $451M -$72.9M -13.9% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-03
Q4 2011 $2.02B $390M -$68M -14.8% Oct 1, 2011 Dec 31, 2011 10-K 2013-03-01
Q3 2011 $2.09B $572M +$129M +29.2% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-01
Q2 2011 $1.96B $535M +$19.4M +3.77% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-01
Q1 2011 $1.94B $524M +$109M +26.4% Jan 1, 2011 Mar 31, 2011 10-K 2013-03-01
Q4 2010 $1.83B $458M Oct 1, 2010 Dec 31, 2010 10-K 2012-02-28
Q3 2010 $443M Jul 1, 2010 Sep 30, 2010 10-K 2012-02-28
Q2 2010 $515M Apr 1, 2010 Jun 30, 2010 10-K 2012-02-28
Q1 2010 $415M Jan 1, 2010 Mar 31, 2010 10-K 2012-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.